Clinical trial Recruiting at 1 site Observational Ages 18 and up

Monitoring anticoagulation and inflammation in patients after heart and vascular surgery

Official title: Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions: Prospective Observational Study

Run by Medical University Innsbruck · NCT06222866 · Data updated 2026-11-12

This study is trying to find the best ways to monitor blood thinning treatments in patients after major heart and vascular surgeries to improve safety and outcomes.

More Delirium trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorMedical University Innsbruck
Academic / other
Locations1 site (Innsbruck, Tyrol)
StatusRecruiting
StartedJune 25, 2024
Main results expectedAugust 1, 2026
Study endsDecember 1, 2026
Registry record updatedNovember 26, 2024
Trial IDNCT06222866 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 17 scheduled for elective cardiac or vascular surgery requiring anticoagulation.

Probably not a fit

Patients who are pregnant or participating in other interventional clinical trials may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the most effective monitoring tools for unfractionated heparin (UFH) in patients undergoing major heart and vascular surgeries. It will compare various monitoring modalities, such as activated clotting time (ACT), activated partial thromboplastin time (aPTT), viscoelastic tests (ROTEM), and anti-Xa levels, to assess their association with adverse events like thrombosis and bleeding. Additionally, the study will explore the relationship between inflammation and delirium in these patients. By identifying the best monitoring practices, the study seeks to enhance patient safety and outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved anticoagulation management and reduced adverse events in patients undergoing heart and vascular interventions.

How similar studies have gone: While this study explores established monitoring techniques, the specific comparative approach to evaluate their effectiveness in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: \> 17 years
* Informed written consent
* Scheduled for cardiac intervention where the use of UFH is expected (elective surgery)
* Scheduled for vascular intervention when the need for perioperative anticoagulation is expected (elective surgery)
* Patients receiving ECMO support

Exclusion Criteria:

* Patients that are known to be pregnant
* Known participation in other interventional clinical trial

Where it's running

  • Medical University Innsbruck
    Innsbruck, Tyrol, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.